pfizer glp-1 drug China has approved Pfizer's treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Pfizer's Appetite for More Obesity
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21












:max_bytes(150000):strip_icc()/VWH-GettyImages-2196287905-42e440cc5f714dfb8793161a905904d9.jpg)





.jpg?v=1749039868)






